Biotechnology & Life Sciences Global On demand · 24-48h

Global Nutrigenomics Reagents & Kits Market Strategic Research Report

Global Nutrigenomics Reagents & Kits Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Nutrigenomics Reagents & Kits Market
$4132025
17.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Saliva, Buccal Swab, Blood

By Application: Online Platforms, Hospitals and Clinics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: GX Sciences Inc., Cura Integrative Medicine, The Gene Box, Holistic Health, Nutrigenomix Inc, Interleukin Genetics, Xcode Life, Metagenics, Inc, DNA Life, Genova Diagnostics, Thermo Fisher, WellGen Inc, Genomix Nutrition Inc

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 101 pages
Market size 2025
$413
Million USD
Forecast CAGR
17.9%
2025-2032
Forecast 2032
$1307.8
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Nutrigenomics Reagents & Kits market size is predicted to grow from US$ 413 million in 2025 to US$ 1,284 million in 2032; it is expected to grow at a CAGR of 17.9% from 2026 to 2032.

Nutrigenomics studies the effect of nutrients on gene expression. In other words, nutrigenomics provides a genetic understanding of how common dietary components affect the balance between health and disease by altering the expression and/or structure of an individual’s genetic make-up. Reagents and kits play a pivotal role in facilitating the collection and analysis of genetic samples, allowing individuals to gain personalized insights into their nutritional needs.

One of the main factors fostering industry expansion is the rising expense of medical care. The CDC estimates that 610,000 Americans each year in the US pass away from heart disease. As more patients spend a lot of money on therapy, medication, and hospitals to enhance their health, the prevalence of these disorders has a direct impact on overall healthcare expenditures. The high cost of name-brand medications raises patients' medical costs. As a result, a lot of individuals choose dietary supplements and fortified dairy products, which are based on nutrigenomics and contain nutrients like vitamins, proteins, and others. Patients are compelled to choose nutrigenomics to address underlying medical issues because of the high expense of medical care. Importantly, people can make wiser choices regarding their diet and health thanks to the availability of nutrigenomics technologies. To manage the rising expenditures of healthcare and lessen the burden of illnesses and health concerns, people are choosing nutrigenomics more frequently. As a result, the market is expanding due to a rapidly increasing demand for nutrigenomics. Thus, this factor is driving the market CAGR.

This report presents a comprehensive overview of the global Nutrigenomics Reagents & Kits market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Saliva
  • Buccal Swab
  • Blood

Segment by Application

  • Online Platforms
  • Hospitals and Clinics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nutrigenomics Reagents & Kits market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Online Platforms, Hospitals and Clinics, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Nutrigenomics Reagents & Kits Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 17.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$413
2025
Forecast
$1307.8
2032
CAGR
17.9%
2025–2032
区域
5
global
Key companies
GX Sciences Inc.Cura Integrative MedicineThe Gene BoxHolistic HealthNutrigenomix IncInterleukin GeneticsXcode LifeMetagenics, Inc
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
SalivaBuccal SwabBlood
By Application
Online PlatformsHospitals and ClinicsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Saliva
  • 3.1.3 Buccal Swab
  • 3.1.4 Blood
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Online Platforms
  • 4.1.3 Hospitals and Clinics
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GX Sciences Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cura Integrative Medicine
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 The Gene Box
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Holistic Health
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Nutrigenomix Inc
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Interleukin Genetics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Xcode Life
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Metagenics, Inc
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 DNA Life
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Genova Diagnostics
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Thermo Fisher
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 WellGen Inc
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Genomix Nutrition Inc
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Nutrigenomics Reagents & Kits market size?
The global Nutrigenomics Reagents & Kits market is estimated at US$ 413 million in 2025 (base year) and is projected to reach US$ 1.28 billion by 2032.
What growth rate is expected for the Nutrigenomics Reagents & Kits market through 2032?
The market is expected to grow at a CAGR of 17.9% from 2026 to 2032, expanding from US$ 413 million in 2025 to US$ 1.28 billion in 2032, roughly 3.1 times its base-year value.
How is Nutrigenomics Reagents & Kits defined?
Nutrigenomics studies the effect of nutrients on gene expression. In other words, nutrigenomics provides a genetic understanding of how common dietary components affect the balance between health and disease by altering the expression and/or structure of an individual’s genetic make-up. Reagents and kits play a pivotal role in facilitating the collection and analysis of genetic samples, allowing individuals to gain personalized insights into their nutritional needs.
How is the Nutrigenomics Reagents & Kits market segmented by type?
By type, the market is segmented into Saliva, Buccal Swab and Blood.
What are the key applications of Nutrigenomics Reagents & Kits?
Key applications covered include Online Platforms, Hospitals and Clinics and Others.
Which companies are profiled in the Nutrigenomics Reagents & Kits market report?
Key players profiled include GX Sciences Inc., Cura Integrative Medicine, The Gene Box, Holistic Health, Nutrigenomix Inc, Interleukin Genetics, Xcode Life and Metagenics, among 13 companies covered in total.
What geographies does the Nutrigenomics Reagents & Kits market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Nutrigenomics Reagents & Kits market report?
The report is intended for manufacturers and solution providers, distributors and end users in Online Platforms, Hospitals and Clinics and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Nutrigenomics Reagents & Kits market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.